NCT01672788View on ClinicalTrials.gov

Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

Empagliflozin

empagliflozin tablets and metformin tablet

DRUG

Empagliflozin + Metformin

fixed dose combination tablet (low)

DRUG

Metformin

empagliflozin tablets and metformin tablet

DRUG

Metformin

empagliflozin tablet and metformin tablet

DRUG

Empagliflozin + Metformin

fixed dose combination tablet (low)

DRUG

Empagliflozin

empagliflozin tablet and metformin tablet

Trial Locations (1)

Unknown

1276.7.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01672788 - Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets | Biotech Hunter | Biotech Hunter